Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Dedicated cardiovascular outcomes trials for tirzepatide are ongoing
The primary indication for therapy is paramountpatients using these medications for type 2 diabetes management typically require long-term treatment as part of comprehensive disease management, whereas those using GLP-1 agents solely for weight management may have more flexibility depending on their response and circumstances
Clinical trials suggest Orforglipron may provide greater weight loss and blood sugar improvements compared to oral semaglutide, along with easier administration
29 July 2017
BPC-157: The Multi-System Repair Signal BPC stands for body protection compound. The 157 refers to its specific sequence of amino acids
Both products contain tirzepatide, a dual GIP and GLP-1 receptor agonist with a 5-day half-life
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
